Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2,5-Dihydroxybenzoic acid → Sitagliptin
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2,5-Dihydroxybenzoic acid | HCID 3469 | — |
| 반응물 | Sitagliptin | HCID 4369359 | — |
| 용매 | Isopropanol | HCID 3776 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 생성물 | Sitagliptin | HCID 4369359 | — |
| 생성물 | HCID 178524607 | HCID 178524607 | — |
반응 단계
The gentisic acid salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine was formed by mixing gentisic acid (0.113 g), (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine (0.300 g) in a mixture of isopropylalcohol (0.6 mL) and chloroform (1.5 mL), followed by stirring at reflux temperature for 2 h. The solvent was distilled out at reduced pressure to obtain solid gentisate salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine as an amorphous solid. [Wt.: 0.410 g, % purity: 98.9%, XRD=amorphous FIG. (2)].
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09108972B2 |
| 출처 데이터셋 | uspto-grants-2015_08 |
| ORD ID | ord-9100f59b1c374987bd7eddfe4157030f |
| 출처 메모 | uspto-grants-2015_08 |